Direkt zum Inhalt
Merck

[A heart without overspeed trip unit].

Praxis (2014-04-24)
Roman Gähwiler, Christian Templin, Thomas F Lüscher, Jelena-Rima Ghadri
ZUSAMMENFASSUNG

We report the case of a 38-year patient who presented in our outpatient clinic for cardiac evaluation and assessment as volunteer firefighter. The patient had an asymptomatic sinustachycardia, which was diagnosed at the age of 15. After we excluded secondary etiologies, as well as a postural orthostatic tachycardia syndrome (POTS) diagnosis of inappropriate sinus tachycardia (IST) was confirmed. A metoprolol therapy was established, however to resistant tachycardia, we suggested a combined therapy of Bisoprolol and Ivabradin, which resulted successfully in normocard sinus rhythm.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
(±)-Metoprolol, ≥98% (titration), powder
USP
Bisoprololfumarat, United States Pharmacopeia (USP) Reference Standard
USP
Metoprolol -tartrat, United States Pharmacopeia (USP) Reference Standard
Supelco
Metoprolol-Tartrat, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Metoprolol tartrate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Bisoprolol -hemifumarat (Salz), ≥98% (HPLC), solid
Bisoprololfumarat, European Pharmacopoeia (EP) Reference Standard
Metoprolol -tartrat, European Pharmacopoeia (EP) Reference Standard
Bisoprolol für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Bisoprolol für die Systemeignung, European Pharmacopoeia (EP) Reference Standard